Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti tumor Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of estrone amino acid ester intermediates via patent CN102127137A. Enhancing 2-ME bioavailability through D-ring modification for reliable pharmaceutical supply.
Patent CN110183467B details a novel 1,3-dipolar cycloaddition route for spiro-indazole derivatives, offering cost-effective manufacturing and high purity for antitumor applications.
Patent CN110835341A details a mild oxidative coupling method for tetrahydrocarboline derivatives with high yields, offering cost-effective routes for antitumor drug development.
Patent CN108658812B details a novel one-step Pd-catalyzed synthesis of alpha-alkoxy-alpha-nitrosoacetates, offering high atom economy and streamlined supply chain solutions for API manufacturing.
Novel anti-tumor silybin derivatives via CN116444505A. Enhanced potency and scalable synthesis for pharmaceutical intermediates supply chain optimization.
Patent CN112979665B details novel griseofulvin derivatives with potent antitumor activity via Schmidt rearrangement, offering cost-effective routes for API intermediates.
Patent CN101440092B reveals novel CDK7 inhibitors. We offer cost-effective manufacturing and reliable supply chain solutions for these complex antitumor intermediates.
Patent CN104557887B reveals a novel 1,8-naphthalimide synthesis with significant antitumor activity. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN113185465A reveals a high-yield Stille coupling route for 4-ethyl-5-aminopyrimidine, offering significant cost reduction in pharmaceutical intermediate manufacturing through mild conditions.
Novel synthesis of oxindole spliced derivatives via MBH carbonates offering high purity and scalable antitumor intermediate production for global supply chains.
Patent CN107235902A details a mild synthesis route for antitumor licochalcone A derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113999214B reveals a novel Rh-catalyzed route for indole dihydrofuran derivatives, offering high stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112724063A details a high-yield copper-catalyzed route for 3-iodo-4-amino maleimides, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN101830961A details novel ursolic acid esters with enhanced antitumor activity via efficient Claisen-Schmidt condensation and esterification routes suitable for scale-up.
Patent CN101824038B details a high-yield Pd/C and iodine-catalyzed route for camptothecin analogues, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108727323B details a green NHC-catalyzed route for trifluoromethyl homoisoflavones, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel chiral phase transfer catalysis enables high-purity indole derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediate supply chains globally.
Patent CN113735826A details a safe Pd-catalyzed carbonylation route for 3-benzylidene-2,3-dihydroquinolones, offering cost reduction in API manufacturing and scalable production.
Patent CN112239456B details a novel Pd-catalyzed carbonylation for 2,3-dihydroquinolones. This method offers high efficiency, broad substrate scope, and significant cost reduction in API manufacturing.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering scalable solutions for reliable pharmaceutical intermediate suppliers.